Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gliosarcoma 2Glioblastoma 2Gallbladder Neoplasms 2Central Nervous System Neoplasms 2Brain Neoplasms 2Bile Duct Neoplasms 2Astrocytoma 2Glioma 1Esophageal Squamous Cell Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 21Radiotherapy 16Fluorouracil 16Paclitaxel 15Irinotecan 8Docetaxel 8Neoadjuvant Therapy 6Drug Therapy 5tislelizumab 4sintilimab 4Surgical Procedures, Operative 4Radiation 4Oxaliplatin 4Leucovorin 4Esophagectomy 4Capecitabine 4toripalimab 3pembrolizumab 3TP protocol 3Chemotherapy, Adjuvant 3S 1 (combination) 2Levoleucovorin 2Injections 2Cetuximab 2Carboplatin 2lenvatinib 1irinotecan sucrosofate 1durvalumab 1atropine sulfate-diphenoxylate hydrochloride drug combination 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Esophageal Squamous Cell Carcinoma × Dihematoporphyrin Ether × Clear all
NCT02628665 2015-12-11

Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer

The First Affiliated Hospital of Henan University of Science and Technology

Phase 3 Unknown
40 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡